Cargando…

Discovery of new non-pyrimidine scaffolds as Plasmodium falciparum DHFR inhibitors by fragment-based screening

In various malaria-endemic regions, the appearance of resistance has precluded the use of pyrimidine-based antifolate drugs. Here, a three-step fragment screening was used to identify new non-pyrimidine Plasmodium falciparum dihydrofolate reductase (PfDHFR) inhibitors. Starting from a 1163-fragment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hoarau, Marie, Vanichtanankul, Jarunee, Srimongkolpithak, Nitipol, Vitsupakorn, Danoo, Yuthavong, Yongyuth, Kamchonwongpaisan, Sumalee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759724/ https://www.ncbi.nlm.nih.gov/pubmed/33530764 http://dx.doi.org/10.1080/14756366.2020.1854244

Ejemplares similares

Molecular Docking Studies, Synthesis and Biological Evaluation of Substituted Pyrimidine‐2,4‐diamines as Inhibitors of Plasmodium falciparum Dihydrofolate Reductase
por: Somandi, Khonzisizwe, et al.
Publicado: (2022)

Selection of drug resistant mutants from random library of Plasmodium falciparum dihydrofolate reductase in Plasmodium berghei model
por: Tipsuwan, Wachiraporn, et al.
Publicado: (2011)

Validation of Plasmodium falciparum deoxyhypusine synthase as an antimalarial target
por: Aroonsri, Aiyada, et al.
Publicado: (2019)

Assay Development and Identification of the First Plasmodium falciparum 7,8-dihydro-6-hydroxymethylpterin-pyrophosphokinase Inhibitors
por: Hoarau, Marie, et al.
Publicado: (2022)

Transgenic Plasmodium parasites stably expressing Plasmodium vivax dihydrofolate reductase-thymidylate synthase as in vitro and in vivo models for antifolate screening
por: Somsak, Voravuth, et al.
Publicado: (2011)

5-Phenoxy Primaquine Analogs and the Tetraoxane Hybrid as Antimalarial Agents
por: Jansongsaeng, Somruedee, et al.
Publicado: (2021)

A Genetically Hard-Wired Metabolic Transcriptome in Plasmodium falciparum Fails to Mount Protective Responses to Lethal Antifolates
por: Ganesan, Karthikeyan, et al.
Publicado: (2008)

Hybrid Inhibitors of Malarial Dihydrofolate Reductase with Dual Binding Modes That Can Forestall Resistance
por: Tarnchompoo, Bongkoch, et al.
Publicado: (2018)

Scalable synthesis of favipiravir via conventional and continuous flow chemistry
por: Tiyasakulchai, Thanat, et al.
Publicado: (2021)

Inducible Knockdown of Plasmodium Gene Expression Using the glmS Ribozyme
por: Prommana, Parichat, et al.
Publicado: (2013)

Plasmodium parasites mount an arrest response to dihydroartemisinin, as revealed by whole transcriptome shotgun sequencing (RNA-seq) and microarray study
por: Shaw, Philip J., et al.
Publicado: (2015)

Concurrence of Plasmodium falciparum dhfr and crt mutations in northern Ghana
por: Mockenhaupt, Frank P, et al.
Publicado: (2005)

Biochemical and functional characterization of Plasmodium falciparum GTP cyclohydrolase I
por: Kümpornsin, Krittikorn, et al.
Publicado: (2014)

Monitoring drug resistance in Plasmodium falciparum clinical isolates collected from Northern Thailand
por: Uthaipibull, Chairat, et al.
Publicado: (2014)

MOLECULAR SURVEILLANCE OF Plasmodium vivax AND Plasmodium falciparum DHFR MUTATIONS IN ISOLATES FROM SOUTHERN IRAN
por: SHARIFI-SARASIABI, Khojasteh, et al.
Publicado: (2016)

Global gene expression profiling of Plasmodium falciparum in response to the anti-malarial drug pyronaridine
por: Kritsiriwuthinan, Kanyanan, et al.
Publicado: (2011)

Identifying transcript 5′ capped ends in Plasmodium falciparum
por: Shaw, Philip J., et al.
Publicado: (2021)

Genome-wide functional screening of drug-resistance genes in Plasmodium falciparum
por: Iwanaga, Shiroh, et al.
Publicado: (2022)

In vitro susceptibility to pyrimethamine of DHFR I164L single mutant Plasmodium falciparum
por: Andriantsoanirina, Valérie, et al.
Publicado: (2011)

Slipknot or Crystallographic Error: A Computational Analysis of the Plasmodium falciparum DHFR Structural Folds
por: Tata, Rolland B., et al.
Publicado: (2022)

The structure of Plasmodium falciparum serine hydroxymethyltransferase reveals a novel redox switch that regulates its activities
por: Chitnumsub, Penchit, et al.
Publicado: (2014)

Transcriptomic complexity of the human malaria parasite Plasmodium falciparum revealed by long-read sequencing
por: Shaw, Philip J., et al.
Publicado: (2022)

Plasmodium serine hydroxymethyltransferase: indispensability and display of distinct localization
por: Pornthanakasem, Wichai, et al.
Publicado: (2012)

Inhibitory effect of novel iron chelator, 1-(N-acetyl-6-aminohexyl)-3-hydroxy-2-methylpyridin-4-one (CM1) and green tea extract on growth of Plasmodium falciparum
por: Thipubon, Phitsinee, et al.
Publicado: (2015)

Homology building as a means to define antigenic epitopes on dihydrofolate reductase (DHFR) from Plasmodium falciparum
por: Alifrangis, Michael, et al.
Publicado: (2004)

Structures of Plasmodium vivax serine hydroxymethyltransferase: implications for ligand-binding specificity and functional control
por: Chitnumsub, Penchit, et al.
Publicado: (2014)

High prevalence of dhfr and dhps molecular markers in Plasmodium falciparum in pregnant women of Nchelenge district, Northern Zambia
por: Siame, Mwiche NP, et al.
Publicado: (2015)

High prevalence of mutation in the Plasmodium falciparum dhfr and dhps genes in field isolates from Sabah, Northern Borneo
por: Abdullah, Noor Rain, et al.
Publicado: (2013)

Cloning and heterologous expression of Plasmodium ovale dihydrofolate reductase-thymidylate synthase gene
por: Tirakarn, Srisuda, et al.
Publicado: (2012)

Fighting Antibiotic Resistance: New Pyrimidine-Clubbed Benzimidazole Derivatives as Potential DHFR Inhibitors
por: Haque, M. Akiful, et al.
Publicado: (2023)

Antagonistic antimalarial properties of a methoxyamino chalcone derivative and 3-hydroxypyridinones in combination with dihydroartemisinin against Plasmodium falciparum
por: Kampoun, Tanyaluck, et al.
Publicado: (2023)

Plasmodium serine hydroxymethyltransferase as a potential anti-malarial target: inhibition studies using improved methods for enzyme production and assay
por: Sopitthummakhun, Kittipat, et al.
Publicado: (2012)

Polymorphism in dhfr/dhps genes, parasite density and ex vivo response to pyrimethamine in Plasmodium falciparum malaria parasites in Thies, Senegal()
por: Ndiaye, Daouda, et al.
Publicado: (2013)

Discovery of a Multifunctional Octapeptide from Lingzhi with Antioxidant and Tyrosinase Inhibitory Activity
por: Yingchutrakul, Yodying, et al.
Publicado: (2022)

Isolation of bioactive compounds from medicinal plants used in traditional medicine: Rautandiol B, a potential lead compound against Plasmodium falciparum
por: Dawurung, Christiana J., et al.
Publicado: (2021)

Genetic mutations in Plasmodium falciparum and Plasmodium vivax dihydrofolate reductase (DHFR) and dihydropteroate synthase (DHPS) in Vanuatu and Solomon Islands prior to the introduction of artemisinin combination therapy
por: Gresty, Karryn J, et al.
Publicado: (2014)

The Fragmented Mitochondrial Ribosomal RNAs of Plasmodium falciparum
por: Feagin, Jean E., et al.
Publicado: (2012)

Identification of 2,4-diamino-6,7-dimethoxyquinoline derivatives as G9a inhibitors
por: Srimongkolpithak, Nitipol, et al.
Publicado: (2014)

N-Containing α-Mangostin Analogs via Smiles Rearrangement as the Promising Cytotoxic, Antitrypanosomal, and SARS-CoV-2 Main Protease Inhibitory Agents
por: Pyae, Nan Yadanar Lin, et al.
Publicado: (2023)

Rapid increase of Plasmodium falciparum dhfr/dhps resistant haplotypes, after the adoption of sulphadoxine-pyrimethamine as first line treatment in 2002, in southern Mozambique
por: Enosse, Sonia, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_ln5u4nkvbiti406e5cn6bk2npl